At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KLRA Kailera Therapeutics
Post-Mkt 04-20 17:43:27 EDT
24.61
-1.39
-5.35%
盘后24.48
-0.13-0.51%
17:28 EDT
High28.23Low23.69Vol1.34M
Open26.50D1 Closing26.00Amplitude17.45%
Mkt Cap2.90BTradable Cap820.33MTotal Shares117.95M
T/O34.87MT/O Rate4.02%Tradable Shares33.33M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Kailera Therapeutics Closes Initial Public Offering
MT Newswires Live  ·  38 minutes ago
Kailera Therapeutics Closes Initial Public Offering
Stock Track | Kailera Therapeutics Plummets 5.35% Intraday on Corporate Governance Changes
Stock Track  ·  04:22
Stock Track | Kailera Therapeutics Plummets 5.35% Intraday on Corporate Governance Changes
Kailera Therapeutics adopts amended bylaws setting new stockholder proposal, director nomination rules
Reuters  ·  04:19
Kailera Therapeutics adopts amended bylaws setting new stockholder proposal, director nomination rules
Kailera Therapeutics closes IPO, raises USD 718.8 million at USD 16 share
Reuters  ·  04:10
Kailera Therapeutics closes IPO, raises USD 718.8 million at USD 16 share
Kailera Stock (KLRA) Rockets 68% after IPO as It Chases $76B Obesity Opportunity
TIPRANKS  ·  04-18
Kailera Stock (KLRA) Rockets 68% after IPO as It Chases $76B Obesity Opportunity
Weight-Loss Drug Developer Kailera Therapeutics Soars Over 50% in U.S. Market Debut
Stock News  ·  04-18
Weight-Loss Drug Developer Kailera Therapeutics Soars Over 50% in U.S. Market Debut
Stock Track | Kailera Therapeutics Soars 62.50% in Intraday Trading on Strong Nasdaq Debut After $625 Million IPO
Stock Track  ·  04-18
Stock Track | Kailera Therapeutics Soars 62.50% in Intraday Trading on Strong Nasdaq Debut After $625 Million IPO
Kailera Therapeutics Shares Open for Trading at $26 in Nasdaq Debut VS U.S. IPO Price of $16 Each
THOMSON REUTERS  ·  04-18
Kailera Therapeutics Shares Open for Trading at $26 in Nasdaq Debut VS U.S. IPO Price of $16 Each
BUZZ-Obesity drug developer Kailera on track for Nasdaq debut above offer price
Reuters  ·  04-17
BUZZ-Obesity drug developer Kailera on track for Nasdaq debut above offer price
Weight-Loss Drug Contender Kailera Therapeutics (KLRA.US) Raises $625 Million in Largest US Biotech IPO Since 2021, Set for Nasdaq Debut
Stock News  ·  04-17
Weight-Loss Drug Contender Kailera Therapeutics (KLRA.US) Raises $625 Million in Largest US Biotech IPO Since 2021, Set for Nasdaq Debut
Kailera Therapeutics 39.06M share IPO priced at $16.00
TIPRANKS  ·  04-17
Kailera Therapeutics 39.06M share IPO priced at $16.00
BRIEF-Kailera Therapeutics Announces Pricing Of Initial Public Offering
Reuters  ·  04-17
BRIEF-Kailera Therapeutics Announces Pricing Of Initial Public Offering
Kailera Therapeutics Announces Pricing of Initial Public Offering
GlobeNewswire  ·  04-17
Kailera Therapeutics Announces Pricing of Initial Public Offering
Kailera Therapeutics Sets IPO Price Range at $14-$16 Per Share, Aims for Nasdaq Listing This Friday
Stock News  ·  04-14
Kailera Therapeutics Sets IPO Price Range at $14-$16 Per Share, Aims for Nasdaq Listing This Friday

Introduction

Company Name.
Kailera Therapeutics
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--